Danaparoid

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Synonym(s)

Danaparoid sodium

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Danaparoid sodium (mixture of low molecular weight sulphated glycosaminoglycans - dermatan, chondrotin and heparan sulphate - from animal intestinal mucosa). Selective factor Xa inhibitor. Danaparoid shows no cross-reaction to heparin-associated antibodies and is therefore the drug of choice in patients with HIT-2.

Half-lifeThis section has been translated automatically.

24.5 hours.

IndicationThis section has been translated automatically.

Thrombosis prophylaxis in patients with heparin-associated thrombopenia and after allergic reactions to systemic heparins (see heparin-induced thrombocytopenia).

Dosage and method of useThis section has been translated automatically.

Prophylaxis of deep vein thrombosis: 2 times/day 750 IU/day s.c; for the treatment of HIT-2: intial 2500 IU. i.v. At KG < 55kg 1250 IU., at > 90 kg 3750 IU., then 400 IU/h over 3 hours. Maintenance dose: 150-200 IU/h. Contraindication in renal and hepatic failure.

Remember! No i.m. application!

PreparationsThis section has been translated automatically.

Orgaran

LiteratureThis section has been translated automatically.

  1. Greinacher A et al (2003) Heparin-induced thrombocytopenia. Dtsch Ärztebl 100: 2220-2229
  2. HA Neumann (2014) The coagulation system. ABW-Scientific Publisher GmbH Berlin

Authors

Last updated on: 29.10.2020

Author: Prof. Dr. med. Peter Altmeyer